PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.

1. (1) Schedules of Controlled Substances.

   1. (A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

      1. 1. Opiates. Unless specifically excepted or unless listed in

another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)- 4-piperidinyl)-N- phenylacetamide)
2. B. Acetylmethadol
3. C. Acetyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide)
4. D. N-(1-phenethylpiperidin- 4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: acryl fentanyl, acryloylfentanyl)
5. E. AH-7921(3,4-dichloro- N-[(1-dimethylamino) cyclohexylmethyl] benzamide)
6. F. Allylprodine
7. G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alphaacetylmethadol levothadyl acetate or LAAM)
8. H. Alphameprodine
9. I. Alphamethadol
10. J. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl- 2-phenylethyl)-4 ((N- propanilido) piperidine)
11. K. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- phenylpropanamide)
12. L. Benzethidine
13. M. Betacetylmethadol
14. N. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2- phenethyl)-4-piperidinyl)- N-phenylpropanamide)

1. O. Beta-hydroxy-3- methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)- 3-methyl-4-piperidinyl)-N- phenylpropanamide)
2. P. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (Other names: beta-hydroxythiofentanyl)
3. Q. Betameprodine
4. R. Betamethadol
5. S. beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl) propionamide (Other name: β-methyl fentanyl)
6. T. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide (Other names: β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)
7. U. Betaprodine
8. V. Clonitazene
9. W. Crotonyl fentanyl ((E)-N-(1- phenethylpiperidin-4-yl)-N- phenylbut-2-enamide)
10. X. N-(1-phenethylpiperidin- 4-yl)-N- Phenylcyclopentanecarboxamide (Other name: cyclopentyl fentanyl)
11. Y. Cyclopropyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide)
12. Z. Dextromoramide AA. Diampromide BB. Diethylthiambutene
13. CC. Difenoxin
14. DD. Dimenoxadol EE. Dimepheptanol FF. Dimethylthiambutene GG. Dioxaphetyl butyrate HH. Dipipanone
15. II. Ethylmethylthiambutene JJ. Etonitazene KK. Etoxeridine
16. LL. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate)
17. MM. N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4- yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl) NN. 2'-Fluoro orthofluorofentanyl (N-(1-(2- fluorophenethyl) piperidin- 4-yl)-N-(2-fluorophenyl) propionamide (Other names: 2'-fluoro 2- fluorofentanyl) OO. N-(1-phenethylpiperidin- 4-yl)-N-phenylfuran-2- carboxamide (Other names: furanyl fentanyl) PP. Furethidine QQ. Hydroxypethidine RR. N-(1-phenethylpiperidin- 4-yl)-N-phenylisobutyramide (Other name: isobutyryl fentanyl) SS. Ketobemidone TT. Levomoramide UU. Levophenacylmorphan
18. VV. Methoxyacetyl fentanyl (2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide WW. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N- phenylacetamide)
19. XX. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)-4- piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers YY. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- N-phenylpropanamide) ZZ. Morpheridine AAA. MPPP (1-methyl-4- phenyl-4- propionoxypiperidine) BBB. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine)
20. CCC. Noracymethadol
21. DDD. Norlevorphanol EEE. Normethadone FFF. Norpipanone GGG. N-(2-fluorophenyl)-2- methoxy-N-(1- phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: ocfentanil) HHH. ortho-Fluoroacryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) acrylamide) (9560)
22. III. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide (Other Name: 2-fluorobutyryl fentanyl) JJJ. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl) KKK. ortho-Fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide)
23. LLL. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (Other name: 2-methyl acetylfentanyl)
24. MMM. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (Other name: 2-methyl methoxyacetyl fentanyl) NNN. N-(4-chlorophenyl)-N- (1-phenethylpiperidin- 4-yl)isobutyramide (Other name: parachloroisobutyryl fentanyl) OOO. para-Fluorobutyryl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)butyramide) PPP. Para-fluorofentanyl(N- (4-fluorophenyl)-N-(1-(2- phenethyl)-4-piperidinyl) propanamide QQQ. para-Fluoro furanyl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)furan-2-carboxamide) RRR. para-Methoxybutyryl fentanyl (N-(4- methoxyphenyl)-N-(1- phenethylpiperidin-4-yl) butyramide) SSS. para-Methylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl) propionamide (Other Name: 4- methylfentanyl) TTT. PEPAP (1-(-2-phenethyl)- 4-phenyl-4- acetoxypiperidine) UUU. Phenadoxone
25. VVV. Phenampromide WWW. Phenomorphan
26. XXX. Phenoperidine YYY. Phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylbenzamide (Other name: benzoyl fentanyl) ZZZ. Piritramide AAAA. Proheptazine BBBB. Properidine
27. CCCC. Propiram
28. DDDD. Racemoramide EEEE. N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran- 2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: tetrahydrofuranyl fentanyl) FFFF. Thiofentany (N-phenyl- N-(1-(2-thienyl)ethyl-4- piperidinyl)- propanamide GGGG. Thiofuranyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-N-phenylthiophene- 2-carboxamide (Other names: 2-thiofuranyl fentanyl; thiophene fentanyl) HHHH. Tilidine
29. IIII. Trimeperidine
30. 2. Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
31. A. Acetorphine
32. B. Acetyldihydrocodeine
33. C. Benzylmorphine
34. D. Codeine methylbromide
35. E. Codeine-N-Oxide
36. F. Cyprenorphine
37. G. Desomorphine
38. H. Dihydromorphine
39. I. Drotebanol
40. J. Etorphine (except hydrochloride salt)
41. K. Heroin
42. L. Hydromorphinol
43. M. Methyldesorphine
44. N. Methyldihydromorphine
45. O. Morphine methylbromide
46. P. Morphine methylsulfonate
47. Q. Morphine-N-Oxide
48. R. Myrophine
49. S. Nicocodeine
50. T. Nicomorphine
51. U. Normorphine
52. V. Pholcodine
53. W. Thebacon

54. 3. Opiate Similar Synthetic Substances. Substances scheduled by the United States Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another 9641 schedule. These substances are—

    1. 4. Hallucinogenic substances. Unless specifically excepted

    or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)4. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

    Some trade or other names: etryptamine; Monase; alpha-ethyl- 1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

    Some trade or other names: 4-bromo-2, 5-dimethoxy-amethylphenethylamine; 4-bromo- 2, 5-DMA;

    Some amethylphenethylamine; 2,5-DMA;

    Some trade or other names: DOET;

55. A. Butyryl fentanyl (N- (1-phenethylpiperidin-4-yl)- N-phenylbutyramide)
56. B. U–47700 (3,4-Dichloro- N-[2-(dimethylamino) cyclohexyl]-N- methylbenzamide)
57. C. N-(1-phenethylpiperidin- 4-yl)-N-phenylpentanamide (Other name: valeryl fentanyl)
58. A. Alpha-ethyltryptamine
59. B. 4-bromo-2,5-dimethoxyamphetamine
60. C. 4-bromo-2,5-dimethoxyphenethylamine
61. D. 2,5-dimethoxyamphetamine trade or other names: 2,5-dimethoxy-
62. E. 2,5-dimethoxy-4-ethylamphetamine
63. F. 2,5-dimethoxy-4-(n)- propylthiophenethylamine (other name: 2C-T-7)
64. G. 2-(2,5-Dimethoxy-4-(n)- propylphenyl) ethanamine (2C-P)
65. H. 2-(2,5-Dimethoxy-4- ethylphenyl) ethanamine (2C-E )
66. I. 2-(2,5-Dimethoxy-4- methylphenyl) ethanamine (2C-D)
67. J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N)
68. K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
69. L. 2-(4-Chloro-2,5- dimethoxyphenyl) ethanamine (2C-C)
70. M. 2-(4-Ethylthio-2,5- dimethoxyphenyl) ethanamine (2C-T-2)
71. N. 2-(4-Iodo-2,5- dimethoxyphenyl) ethanamine (2C-I)
72. O. 2-(4-Isopropylthio)-2,5- dimethoxyphenyl) ethanamine (2C-T-4)

73. P. 4-methoxyamphetamine Some trade or other names: 4-methoxy-amethylphenethylamine; paramethoxyamphetamine; PMA;

    1. Q. 5-methoxy-3,4-methylenedioxyamphetamine
    2. R. 4-methyl-2,5-dimethoxyamphetamine

Some trade and other names: 4-methyl-2, 5-dimethoxy-amethylphenethylamine; DOM; and STP;

1. S. 3,4-methylenedioxyamphetamine
2. T. 3,4-methylenedioxymethamphetamine(MDMA)
3. U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)
4. V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)
5. W. 3,4,5-trimethoxyamphetamine
6. X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine
7. Y. Alpha-methyltryptamine
8. Z. Bufotenine

Some trade and other names: 3-(b-Dimethylaminoethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; AA. Diethyltryptamine Some trade and other names: N, N-Diethyltryptamine; DET; BB. Dimethyltryptamine Some trade or other names: DMT;

1. CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)
2. DD. Ibogaine

Some trade and other names: 7-Ethyl- 6,6ß,7,8,9,10,12,13- octahydro-2-methoxy-6, 9-methano-5H-pyrido [1’,2’:1,2] azepino[5,4-b] indole; Tabernanthe iboga; EE. Lysergic acid diethylamide FF. Marihuana Some trade or other names: marijuana; GG. Mescaline HH. Parahexyl Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

1. II. Peyote

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts; JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate

1. LL. Psilocybin
2. MM. Psilocyn NN. Tetrahydrocannabinols naturally contained in a

plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: isomers;

optical isomers;

optical isomers; and

internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered;

Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)- ethylamine, cyclohexamine, PCE;

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

Some trade or other names: 1-(1-(2-thienyl)-cyclohexyl)- piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

Some other names: TCPy;

1. (I) 1 cis or trans tetrahydrocannabinol and their optical
2. (II) 6 cis or trans tetrahydrocannabinol and their
3. (III) 3,4 cis or trans tetrahydrocannabinol and its
4. (IV) Since nomenclature of these substances is not

OO. Ethylamine analog of phencyclidine

PP. Pyrrolidine analog of phencyclidine

QQ. Thiophene analog of phencyclidine

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine

SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone VV. 4-Fluoromethcathinone WW. Mephedrone, or 4- methylmethcathinone XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)- 2-(1-pyrrolidinyl)-1-pentanone YY. Methylone, or 3,4- Methylenedioxy-methcathinone ZZ. Quinolin-8-yl 1-pentyl- 1Hindole-3-carboxylate (PB-22; QUPIC) AAA. Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole- 3-carboxylate (5-fluoro- PB-22; 5F-PB-22) BBB. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (4-fluorobenzyl)-1Hindazole- 3-carboxamide (AB-FUBINACA) CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA) DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3- tetramethylcyclopropyl) methanone (Other names: UR-144, 1-pentyl-3-(2,2,3,3- tetramethylcyclopropoyl)indole) EEE. [1-(5-fluoro-pentyl)- 1Hindol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (Other names: 5-fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole) FFF. N-(1-adamantyl)-1-pentyl- 1Hindazole-3-carboxamide (Other names: APINACA, AKB48) GGG. 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 251- NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) HHH. 2-(4-chloro-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 25C- NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) III. 2-(4-bromo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (Other names: 25B- NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) JJJ. 4-methyl-N-ethylcathinone (Other names: 4-MEC; 2- (ethylamino)-1-(4- methylphenyl)propan-1-one) KKK. 4-methyl-alphapyrrolidinopropiophenone, (Other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2- (pyrrolidin-1-yl)-propan-1-one) LLL. alphapyrrolidinopentiophenone (Other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one) MMM. Butylone (Other names: bk- MBDB; 1-(1,3- benzodioxol-5- yl)-2- (methylamino)butan-1-one) NNN. Pentedrone (Other names: α- methylaminovalerophenone; 2-(methylamino)-1- phenylpentan-1-one) OOO. Pentylone (Other names: bk- MBDP; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)pentan-1-one) PPP. Naphyrone (Other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one) QQQ. alpha-pyrrolidinobutiophenone (Other names: α-PBP; 1-phenyl-2-(pyrrolidin- 1-yl)butan-1-one) RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole- 3-carboxamide (Other names: AB- CHMINACA) SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (Other names: AB-PINACA) TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (Other names: THJ-2201) UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (Other names: MAB- CHMINACA; ADB-CHMINACA) VVV. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3,3- dimethylbutanoate (Other names: 5F–ADB; 5F–MDMB– PINACA) WWW. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3- methylbutanoate (Other names: 5F–AMB) XXX. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide (Other names: 5F– APINACA, 5F–AKB48) YYY. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole- 3-carboxamide (Other names: ADB–FUBINACA) ZZZ. methyl 2-(1- (cyclohexylmethyl)- 1H-indole- 3-carboxamido)-3,3- dimethylbutanoate (Other names: MDMB–CHMICA, MMB–CHMINACA) AAAA. methyl 2-(1-(4- fluorobenzyl)- 1H-indazole- 3-carboxamido)-3,3- dimethylbutanoate (Other names: MDMB–FUBINACA) BBBB. methyl 2-(1-(4- fluorobenzyl)-1H- indazole- 3-carboxamido)-3- methylbutanoate (Other names: FUB–AMB, MMB– FUBINACA, AMB– FUBINACA) CCCC. 1-(1,3-benzodioxol- 5-yl)-2-(ethylamino) propan-1-one (ethylone) DDDD. Naphthalen-1-yl 1- (5-fluoropentyl)-1H- indole-3-carboxylate (Other names: NM2201; CBL2201) EEEE. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H- indazole-3-carboxamide (Other name: 5F-AB- PINACA) FFFF. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (Other names: 4-CN- CUMYLBUTINACA; 4-cyano-CUMYL- BUTINACA; 4-CN- CUMYLBINACA; CUMYL-4CNBINACA; SGT-78) GGGG. methyl 2-(1- (cyclohexylmethyl)-1H- indole-3-carboxamido)-3- methylbutanoate (Other names: MMB- CHMICA; AMB- CHMICA) HHHH. 1-(5-fluoropentyl)-N- (2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b] pyridine-3-carboxamide (Other name: 5F- CUMYL-P7AICA) IIII. N-ethylpentylone (Other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1-one) JJJJ. methyl 2-(1-(4-fluorobutyl)- 1H-indazole-3- carboxamido)-3, 3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB–BUTINACA) KKKK. 1-(4-methoxyphenyl)-N- methylpropan-2-amine (Other names: paramethoxymethamphetamine, PMMA) LLLL. Synthetic cannabinoids: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. (I) Any compound structurally derived

3-(1-naphthoyl)indole or 1Hindol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,

(7021) 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

1. (II) Any compound structurally derived

7543 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (III) Any compound structurally derived

1-(1-naphthylmethyl)indene 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further

1245 substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (IV) Any compound structurally derived

3-phenylacetylindole by substitution at

1. (a) AM2201, or 1-(5- fluoropentyl)-3- (1-naphthoyl)indole
2. (b) JWH-007, or 1- pentyl-2-methyl- 3-(1-naphthoyl)indole
3. (c) JWH-015, or 1-propyl- 2-methyl-3-(1- naphthoyl)indole
4. (d) JWH-018, or 1-pentyl- 3-(1-naphthoyl)indole
5. (e) JWH-019, or 1-hexyl- 3-(1-naphthoyl)indole
6. (f) JWH-073, or 1-butyl- 3-(1-naphthoyl)indole
7. (g) JWH-081, or 1-pentyl- 3-(4-methoxy-1- naphthoyl)indole
8. (h) JWH-098, or 1-pentyl- 2-methyl-3-(4- methoxy-1- naphthoyl)indole
9. (i) JWH-122, or 1-pentyl- 3-(4-methyl-1- naphthoyl)indole
10. (j) JWH-164, or 1-pentyl- 3-(7-methoxy-1- naphthoyl)indole
11. (k) JWH-200, or 1-(2-(4- (morpholinyl)ethyl))-3- (1-naphthoyl)indole
12. (l) JWH-210, or 1-pentyl- 3-(4-ethyl-1- naphthoyl)indole

13. (m) JWH-398, or 1-pentyl- 3-(4-chloro-1- naphthoyl)indole

    by substitution at

    the nitrogen

from

from

from the

from atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) JWH-201, or 1-pentyl-3-(4- methoxyphenylacetyl)indole
2. (b) JWH-203, or 1-pentyl-3-(2- chlorophenylacetyl)indole
3. (c) JWH-250, or 1-pentyl- 3-(2-methoxyphenylacetyl)indole
4. (d) JWH-251, or 1-pentyl-3-(2- methylphenylacetyl)indole
5. (e) RCS-8, or 1-(2- cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole
6. (V) Any compound structurally derived

2-(3-hydroxycyclohexyl)phenol by substitution at 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

1. (a) CP 47,497 & homologues, or 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7 7297, 7298

1. (VI) Any compound containing a 3-(benzoyl)indole

structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) AM-694, or 1-(5- fluoropentyl)-3-(2- iodobenzoyl)indole
2. (b) RCS-4, or 1-pentyl-3-(4- methoxybenzoyl)indole (SR-19 and RCS-4)
3. (VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-

methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10aoctahydrophenanthridin- 1-yl] acetate; (VIII) HU-210, or (6aR,10aR)-9- (hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;

1. (IX) HU-211, or Dexanabinol,(6aS,10aS)-9-

(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

1. (X) Dimethylheptylpyran, or DMHP.
2. 5. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Gamma-hydroxybutyric acid and other names GHB;

gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate

1. B. Mecloqualone

   1. 6. Stimulants. Unless specifically excepted or unless listed

   in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

   Some trade or other names: aminoxaphen; 2-amino-5-phenyl- 2-oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;

from the

Some trade or other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1- phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; methylcathinine; AL-464; AL-422; AL-463 and URI 432;

(some other names: N,N-alpha-trimethylbenzeneethanamine;

7694 N,N-alpha-trimethylphenethylamine)

1. 7. A temporary listing of substances subject to emergency

scheduling under federal law shall include any material,

7104 compound, mixture, or preparation which contains any quantity of the following substances:

not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;

alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl,

2010 amino, or nitro groups; C. Methaqualone

1. A. Aminorex
2. B. N-benzylpiperazine (some other names: BZP, 1-benzylpiperzaine)
3. C. Cathinone (Some trade or other names: 2-amino-1- phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone)
4. D. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2- oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine)
5. E. Fenethylline

6. F. Methcathinone

   ephedrone; N-methylcathinone;

7. G. 4-methoxymethcathinone
8. H. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine)
9. I. 4-Methyl-alphapyrrolidinobutiophenone, or MPBP
10. J. N-ethylamphetamine
11. K. N,N-dimethylamphetamine

12. A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.

    1. (I) Fentanyl-related substance means any substance

       1. (a) Replacement of the phenyl portion of the
       2. (b) Substitution in or on the phenethyl group with
       3. (c) Substitution in or on the piperidine ring with
       4. (d) Replacement of the aniline ring with any

aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or

1. (e) Replacement of the N-propionyl group by

another acyl group. B. ethyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-EDMB- PINACA) C. methyl 2-(1-(5-fluoropentyl)- 1H-indole-3-carboxamido)-3,3- dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: 5F-MDMB-PICA) D. N-(adamantan-1-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4- FLUOROBENZYL)) E. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial names: 5F-CUMYL-PINACA; SGT-25) F. (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts, and salts of isomers (trivial name: FUB-144) G. N-Ethylhexedrone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other name: 2- (ethylamino)-1-phenylhexan-1-one) H. alpha-Pyrrolidinohexanophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: α-PHP; alphapyrrolidinohexiophenone; 1- phenyl-2-(pyrrolidin-1-yl)hexan-1-one) I. 4-Methyl-alphaethylaminopentiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-MEAP; 2- (ethylamino)-1-(4-methylphenyl)pentan-1-one) J. 4'-Methyl-alpha-pyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)- 2-(pyrrolidin-1-yl)hexan-1-one) 7014 8. Khat, to include all parts of the plant presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts.

1. (B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

   1. 1. Substances, vegetable origin, or chemical synthesis.

Unless specifically excepted or unless listed in another schedule,

7544 Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

1. K. alpha-Pyrrolidinoheptaphenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: PV8; 1-phenyl-2- (pyrrolidin-1-yl)heptan-1-one)
2. L. 4'-Chloro-alphapyrrolidinovalerophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: 4-chloro-α-PVP; 4'- chloro-alphapyrrolidinopentiophenone; 1- (4-chlorophenyl)-2-(pyrrolidin- 1-yl) pentan-1-one)
3. M. N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan- 1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: isotonitazene; N,N-diethyl-2-[[4- (1- methylethoxy) phenyl]methyl]-5-nitro-1H- benzimidazole-1-ethanamine)
4. N. 1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1, 3- dihydro-2H-benzo[d]imidazol- 2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: brorphine; 1-[1-[1-(4-bromophenyl)ethyl]-4- piperidinyl]-1,3-dihydro- 2H-benzimidazol-2-one)

5. A. Opium and opiate; and any salt, compound,

   1. (I) Raw opium
   2. (II) Opium extracts
   3. (III) Opium fluid
   4. (IV) Powdered opium

   5. (V) Granulated opium

      1. (VI) Tincture of opium
      2. (VII) Codeine (VIII) Dihydroetorphine
      3. (IX) Ethylmorphine
      4. (X) Etorphine hydrochloride
      5. (XI) Hydrocodone
      6. (XII) Hydromorphone (XIII) Metopon
      7. (XIV) Morphine
      8. (XV) Oripavine
      9. (XVI) Oxycodone (XVII) Oxymorphone (XVIII) Thebaine
      10. B. Any salt, compound, derivative, or preparation thereof

which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

1. C. Opium poppy and poppy straw
2. D. Coca leaves (9040) and any salt, compound, derivative,

or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:

1. (I) Decocainized coca leaves or extraction of coca

leaves, which extractions do not contain cocaine or ecgonine; or

1. (II) Ioflupane;
2. E. Concentrate of poppy straw (the crude extract of poppy

straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)

1. 2. Opiates. Unless specifically excepted or unless in

another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

1. A. Alfentanil
2. B. Alphaprodine
3. C. Anileridine
4. D. Bezitramide
5. E. Bulk Dextropropoxyphene (Non-dosage Forms)
6. F. Carfentanil
7. G. Dihydrocodeine
8. H. Diphenoxylate
9. I. Fentanyl
10. J. Isomethadone
11. K. Levo-alphacetylmethadol

Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM

1. L. Levomethorphan
2. M. Levorphanol
3. N. Metazocine
4. O. Methadone
5. P. Methadone-Intermediate, 4-cyano-2-dimethylamino- 4,4-diphenyl butane

6. Q. Moramide-Intermediate, 2- methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid

   1. 3. Stimulants. Unless specifically excepted or unless listed

   in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

   1. 4. Depressants. Unless specifically excepted or unless

   listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

   1. 5. Hallucinogenic substances:

   Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydrodibenzo(b,d) pyran-9-one.

   in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

   1. 6. Immediate precursors. Unless specifically excepted or

   unless listed in another schedule, any material, compound,

9254 mixture, or preparation which contains any quantity of the following substances:

methamphetamine:

1. R. Oliceridine (N-[(3- methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin- 2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl})amine fumarate)
2. S. Pethidine (Meperidine)
3. T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4- phenylpiperidine
4. U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4- carboxylate
5. V. Pethidine-Intermediate-C, 1- methyl-4-phenylpiperidine- 4-carboxylic acid
6. W. Phenazocine
7. X. Piminodine
8. Y. Racemethorphan
9. Z. Racemorphan AA. Remifentanil BB. Sufentanil
10. CC. Tapentadol
11. DD. Thiafentanil
12. A. Amphetamine, its salts, optical isomers, and salts of its optical isomers
13. B. Lisdexamfetamine, its salts, isomers, and salts of its isomers
14. C. Methamphetamine, its salts, isomers, and salts of its isomers
15. D. Phenmetrazine and its salts
16. E. Methylphenidate
17. A. Amobarbital
18. B. Glutethimide
19. C. Pentobarbital
20. D. Phencyclidine
21. E. Secobarbital

22. A. Nabilone

    1-hydroxy-6, 6-dimethyl-9H-

23. B. Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]

24. A. Immediate precursor to amphetamine and

    1. (I) Phenylacetone (7365) Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

       1. B. Immediate precursors to phencyclidine (PCP):

          1. (I) 1-phenylcyclohexylamine
          2. (II) 1-piperidinocyclohexanecarbonitrile (PCC)

       2. C. Immediate precursor to fentanyl:

          1. (I) 4-anilino-N-phenethyl-4-piperidine (ANPP)
          2. (II) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)
       3. 7. Any material, compound, mixture, or preparation which

contains any quantity of the following alkyl nitrites:

1. A. Amyl nitrite;
2. B. Butyl nitrite.

3. (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Those compounds, mixtures, or preparations in

dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances 1405

1. B. Benzphetamine
2. C. Chlorphentermine
3. D. Clortermine
4. E. Phendimetrazine
5. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1. A. Any compound, mixture, or preparation containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

1. B. Any suppository dosage form containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;

1. C. Any substance which contains any quantity of a

derivative of barbituric acid or any salt thereof

1. D. Chlorhexadol
2. E. Embutramide
3. F. Any drug product containing gamma hydroxybutyric

acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act; Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2- thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)- 6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin- 7(1H)- one, flupyrazapon.

1. 3. Nalorphine
2. 4. Narcotics drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts

per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1. 5. Any material, compound, mixture, or preparation

containing any of the following narcotic drugs or their salts, as set forth below:

1. 6. Anabolic steroids. Unless specially excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible

2012 within the specific chemical designation. DEA has assigned G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2- (methylamino)-cyclohexanone) H. Lysergic acid I. Lysergic acid amide J. Methyprylon K. Perampanel, and its salts, isomers, and salts of isomers L. Sulfondiethylmethane M. Sulfonethylmethane N. Sulfonmethane O. Tiletamine and zolazepam or any salt thereof

1. A. Not more than one and eight tenths grams (1.8gm) of
2. B. Not more than one and eight tenths grams (1.8gm) of
3. C. Not more than one and eight tenths grams (1.8gm)
4. D. Not more than three hundred milligrams (300 mg)
5. E. Not more than five hundred milligrams (500 mg) of
6. F. Not more than fifty milligrams (50 mg) of morphine

7. A. Buprenorphine code 4000 for all anabolic steroids. Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this paragraph. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:

   1. A. 3β,17β-dihydroxy-5α-androstane
   2. B. 3α,17β-dihydroxy-5α-androstane
   3. C. 5α-androstan-3,17-dione
   4. D. 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)
   5. E. 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)
   6. F. 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)
   7. G. 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)
   8. H. 1-androstenedione ([5α]-androst-1-en-3,17-dione)
   9. I. 4-androstenedione (androst-4-en-3,17-dione)
   10. J. 5-androstenedione (androst-5-en-3,17-dione)
   11. K. Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-

en-3-one)

1. L. Boldenone (17β-hydroxyandrost-1, 4-diene-3-one)
2. M. Boldione (androstra-1,4-diene-3,17-dione)
3. N. Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-

en-3-one)

1. O. Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)
2. P. Dehydrochloromethyltestosterone (4-chloro-17β-

hydroxy-17α-methyl-androst-1, 4-dien-3-one)

1. Q. Desoxymethyltestosterone (17α-methyl-5α-androst-2-

en-17β-ol) (a.k.a. madol)

1. R. Δ1-dihydrotestosterone (a.k.a.’1-testosterone’)(17β-

hydroxy-5α-androst-1-en-3-one)

1. S. 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
2. T. Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-

3-one)

1. U. Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)
2. V. Fluoxymesterone (9-fluoro-17α-methyl-11β,17β-

dihydroxyandrost-4-en-3-one)

1. W. Formebulone (Formebolone) (2-formyl-17α-methyl-

11α,17β-dihydroxyandrost-1,4-dien-3-one)

1. X. Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-

furazan)

1. Y. 13β-ethyl-17β-hydroxygon-4-en-3-one
2. Z. 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-

3-one) AA. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr- 4-en-3-one) BB. Mestanolone (17α-methyl-17β-hydroxy-5α-androstan- 3-one)

1. CC. Mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-

3-one)

1. DD. Methandienone (17α-methyl-17β-hydroxyandrost-1,4-

dien-3-one) EE. Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- ene) FF. Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol- 3-one) GG. Methenolone (1-methyl-17β-hydroxy-5α-androst-1- en-3-one) HH. 17α-methyl-3β,17β-dihydroxy-5α-androstane

1. II. 17α-methyl-3α,17β-dihydroxy-5α-androstane JJ. 17α-methyl-3β,17β-dihydroxyandrost-4-ene KK. 17α-methyl-4-hydroxynandrolone(17α-methyl-4-

hydroxy-17β-hydroxyestr-4-en-3-one)

1. LL. Methyldienolone (17α -methyl-17α-hydroxyestra-

4,9(10)-dien-3-one)

1. MM. Methyltrienolone (17α-methyl-17α-hydroxyestra-

4,9,11-trien-3-one) NN. Methyltestosterone (17α-methyl-17-hydroxyandrost- 4-en-3-one) OO. Mibolerone (7α,17α-dimethyl-17α-hydroxyestr-4-en- 3-one) PP. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- methyl-5α-androst-1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) QQ. Nandrolone (17β-hydroxyestr-4-ene-3-one) RR. 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4- ene) SS. 19-nor-4-andro stenediol (3α,17β-dihydroxyestr-4- ene) TT. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)- diene-3,17-dione) UU. 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5- ene)

1. VV. 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) WW. 19-nor-4-androstenedione (estr-4-en-3,17-dione)
2. XX. 19-nor-5-androstenedione (estr-5-en-3,17-dione) YY. Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-

3-one) ZZ. Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) AAA. Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en- 3-one) BBB. Normethandrolone (17α-methyl-17β-hydroxyestr-4- en-3-one)

1. CCC. Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-

androstan-3-one)

1. DDD. Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-

4-en-3-one) EEE. Oxymetholone (17α-methyl-2-hydroxymethylene- 17β-hydroxy-[5α]-androstan-3-one) FFF. Prostanozol (17β -hydroxy-5α-androstano[3,2-c] pyrazole) GGG. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy-5α-androst-1-en-3-one)) HHH. Stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2- eno[3,2-c]-pyrazole)

1. III. Stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-

3-one) JJJ. Testolactone(13-hydroxy-3-oxo-13,17-secoandrosta-1,4- dien-17-oic acid lactone) KKK. Testosterone(17β-hydroxyandrost-4-en-3-one);

1. LLL. Tetrahydrogestrinone (13β,17α-diethyl-17β -

hydroxygon-4,9, 11-trien-3-one)

1. MMM. Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) NNN. Any salt, ester, or isomer of a drug or substance

described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration.

1. 7. Dronabinol (synthetic) in sesame oil and encapsulated

in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10atetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran- 1-ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

1. (D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Narcotic drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one milligram (1 mg) of difenoxin (DEA

Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit

1. B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-

diphenyl-3-methyl-2-propionoxybutane)

1. C. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)

cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)

1. D. Narcotic drugs containing nonnarcotic active

medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. (I) Not more than two hundred milligrams (200 mg)

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. (II) Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or

1. (III) Not more than one hundred milligrams (100 mg)

of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Alfaxalone
2. B. Alprazolam
3. C. Barbital
4. D. Brexanolone
5. E. Bromazepam
6. F. Camazepam
7. G. Carisoprodol
8. H. Chloral betaine
9. I. Chloral hydrate
10. J. Chlordiazepoxide
11. K. Clobazam
12. L. Clonazepam
13. M. Clorazepate
14. N. Clotiazepam
15. O. Cloxazolam
16. P. Delorazepam
17. Q. Diazepam
18. R. Dichloralphenazone
19. S. Estazolam
20. T. Ethchlorvynol
21. U. Ethinamate

22. V. Ethyl loflazepate

    1. 3. Fenfluramine. Any material, compound, mixture, or

    preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

    1. 4. Lorcaserin. Any material, compound, mixture, or

    preparation which contains any quantity of the following

2145 substances, including its salts, isomers, and salts of isomers, 2400 whenever the existence of such salts, isomers, and salts of 2748 isomers is possible:

8192 5. Stimulants. Unless specifically excepted or unless listed 2460 in another schedule, any material, compound, mixture, or 2465 preparation which contains any quantity of the following 2744 substances having a stimulant effect on the central nervous 2751 system, including its salts, isomers, and salts of isomers: W. Fludiazepam X. Flunitrazepam Y. Flurazepam Z. Fospropofol AA. Halazepam BB. Haloxazolam CC. Ketazolam DD. Lemborexant EE. Loprazolam FF. Lorazepam GG. Lormetazepam HH. Mebutamate II. Medazepam JJ. Meprobamate KK. Methohexital LL. Methylphenobarbital (Mephobarbital) MM. Midazolam NN. Nimetazepam OO. Nitrazepam PP. Nordiazepam QQ. Oxazepam RR. Oxazolam SS. Paraldehyde TT. Petrichloral UU. Phenobarbital VV. Pinazepam WW. Prazepam XX. Quazepam YY. Remimazolam ZZ. Suvorexant AAA. Temazepam BBB. Tetrazepam CCC. Triazolam DDD. Zaleplon EEE. Zolpidem FFF. Zopiclone

1. A. Fenfluramine
2. A. Lorcaserin
3. A. Cathine ((+)-norpseudoephedrine)
4. B. Diethylpropion
5. C. Fencamfamin
6. D. Fenproporex
7. E. Mazindol
8. F. Mefenorex
9. G. Modafinil
10. H. Pemoline (including organometallic complexes and chelates thereof)
11. I. Phentermine

12. J. Pipradrol

    1. K. Serdexmethylphenidate
    2. L. Sibutramine
    3. M. Solriamfetol (2-amino-3- phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))
    4. N. SPA (-)-1-dimethylamino- 1,2-diphenylethane
    5. 6. Other substances. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

1. A. Pentazocine
2. B. Butorphanol (including its optical isomers)
3. C. Eluxadoline (5-[[[(2S)-2- amino-3-[4-aminocarbonyl)- 2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl- 1 H-imidazol-2- yl)ethyl]amino]methyl]-2- methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers
4. 7. Ephedrine. Any material, compound, mixture, or

preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:

1. A. Ephedrine or its salts, optical isomers, or salts of

optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.

1. (E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.

   1. 1. Narcotic drugs containing nonnarcotic active medicinal

ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. A. Not more than two hundred milligrams (200 mg)

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. B. Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. C. Not more than one hundred milligrams (100 mg) of

ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. D. Not more than two and five-tenths milligrams (2.5 mg)

of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

1. E. Not more than one hundred milligrams (100 mg) of

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

1. F. Not more than five-tenths milligram (0.5 mg) of

difenoxin (DEA Drug Code No. 9168) and not less than twentyfive micrograms (25 mcg) of atropine sulfate per dosage unit.

1. 2. Stimulants. Unless specifically exempted or excluded

or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the 1729 following substances having a stimulant effect on the central 1675 nervous system including its salts, isomers, and salts of isomers:

1. 3. Any compound, mixture, or preparation containing

any detectable quantity of pseudoephedrine or its salts or

1650 optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity 1635 of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starch-based solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled 9709 substances:

to be dispensed.

1. 4. Unless specifically exempted or excluded or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

1. (2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo.

1. A. Pyrovalerone
2. A. Drug preparations in liquid form;
3. B. Drug preparations that require a prescription in order
4. A. Ezogabine [N-[2-amino-4(4- fluorobenzylamino)-phenyl]- carbamic acid ethyl ester]
5. B. Lacosamide [(R)-2- acetoamido-N-benzyl- 3-methoxy-propionamide]
6. C. Pregabalin [(S)-3- (aminomethyl)-5- methylhexanoic acid]
7. D. Brivaracetam ((25)-2-[(4R)- 2-oxo-4-propylpyrrolidin-1- yl]butanamide) (also referred to as BRV; UCB-34714; Briviact)
8. E. Lasmiditan [2,4,6-trifluoro-N-(6-(1- methylpiperidine-4- carbonyl) pyridine-2- yl-benzamide]
9. F. Cenobamate ([(1R)-1-(2- chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate; 2H- tetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2- chlorophenyl)-2-(2H-tetrazol- 2-yl)ethyl ester) Company

Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs

AUTHORITY: section 195.015, RSMo Supp. 2021, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. Emergency amendment filed Sept. 28, 2021, effective Oct. 13, 2021, expired April 10, 2022. Amended: Filed Sept. 28, 2021, effective March 30, 2022. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020, and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.